Literature DB >> 7776819

A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.

K L Morse1, D J Fournier, X Li, J Grzybowska, A Makriyannis.   

Abstract

In order to explore the structural requirements for cannabinoid activity we have been involved in the design and synthesis of stereochemically defined high affinity probes for the cannabinoid receptor. This effort has involved the development of irreversible ligands which will allow us to obtain detailed information on the cannabinoid receptor active site(s). The irreversible ligands, which incorporate highly reactive functional groups in a strategic position of the ligand, may form covalent bonds with amino acid residues at the receptor active site or in the neighborhood of this site. We shall discuss the biochemical properties of one of these probes, which incorporates the electrophilic isothiocyanate group into the structure of the highly potent cannabinoid agonist (-)-1',1'-dimethylheptyl-delta 8-THC. This ligand, (-)-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC (7'-NCS-DMH-delta 8-THC), was evaluated for its affinity for cannabinoid binding sites using rat forebrain membrane preparations and found to have an apparent IC50 value of 660 pM. Incubation of the membrane preparation with a ligand concentration of five times the apparent IC50 resulted in the irreversible occupation of nearly all of the receptor specific binding sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776819     DOI: 10.1016/0024-3205(95)00176-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.

Authors:  N L Cluny; V K Vemuri; A P Chambers; C L Limebeer; H Bedard; J T Wood; B Lutz; A Zimmer; L A Parker; A Makriyannis; K A Sharkey
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.

Authors:  Kelly S Sink; Peter J McLaughlin; Jodi Anne T Wood; Cara Brown; Pusheng Fan; V Kiran Vemuri; Yan Peng; Yan Pang; Teresa Olszewska; Teresa Olzewska; Ganesh A Thakur; Alex Makriyannis; Linda A Parker; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

3.  Novel adamantyl cannabinoids as CB1 receptor probes.

Authors:  Ganesh A Thakur; Shama Bajaj; Carol Paronis; Yan Peng; Anna L Bowman; Lawrence S Barak; Marc G Caron; Demon Parrish; Jeffrey R Deschamps; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2013-05-14       Impact factor: 7.446

4.  Heteroadamantyl cannabinoids.

Authors:  Darryl D Dixon; Divakaramenon Sethumadhavan; Tore Benneche; April R Banaag; Marcus A Tius; Ganesh A Thakur; Anna Bowman; Jodianne T Wood; Alexandros Makriyannis
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

5.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

6.  Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Authors:  Shakiru O Alapafuja; Michael S Malamas; Vidyanand Shukla; Alexander Zvonok; Sally Miller; Laura Daily; Girija Rajarshi; Christina Yume Miyabe; Honrao Chandrashekhar; JodiAnne Wood; Sergiy Tyukhtenko; Alex Straiker; Alexandros Makriyannis
Journal:  Bioorg Med Chem       Date:  2018-11-03       Impact factor: 3.641

7.  Conformationally constrained analogues of 2-arachidonoylglycerol.

Authors:  Subramanian K Vadivel; Sundararaman Vardarajan; Richard I Duclos; JodiAnne T Wood; Jianxin Guo; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2007-08-21       Impact factor: 2.823

8.  Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.

Authors:  K S Sink; V K Vemuri; J Wood; A Makriyannis; J D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-07-24       Impact factor: 3.533

9.  Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors.

Authors:  Ki Duk Park; Pierre Morieux; Christophe Salomé; Steven W Cotten; Onrapak Reamtong; Claire Eyers; Simon J Gaskell; James P Stables; Rihe Liu; Harold Kohn
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

10.  Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.

Authors:  Ying Pei; Richard W Mercier; Jenine K Anday; Ganesh A Thakur; Alexander M Zvonok; Dow Hurst; Patricia H Reggio; David R Janero; Alexandros Makriyannis
Journal:  Chem Biol       Date:  2008-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.